Xencor (NASDAQ:XNCR) Rating Reiterated by Wedbush
Wedbush reaffirmed their outperform rating on shares of Xencor (NASDAQ:XNCR – Free Report) in a report released on Thursday, RTT News reports. The firm currently has a $34.00 target price on the biopharmaceutical company’s stock, down from their previous target price of $36.00. Several other equities analysts have also commented on XNCR. Piper Sandler restated […]
More Stories
China Yuchai International Limited (NYSE:CYD) Short Interest Update
China Yuchai International Limited (NYSE:CYD – Get Free Report) was the target of a significant increase in short interest in...
Hang Lung Properties Limited (OTCMKTS:HLPPY) Short Interest Up 126.7% in September
Hang Lung Properties Limited (OTCMKTS:HLPPY – Get Free Report) was the target of a significant growth in short interest during...
Accenture (NYSE:ACN) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS
Accenture (NYSE:ACN – Get Free Report) announced its earnings results on Thursday. The information technology services provider reported $2.79 EPS...
Short Interest in The Sage Group plc (OTCMKTS:SGPYY) Decreases By 50.0%
The Sage Group plc (OTCMKTS:SGPYY – Get Free Report) was the target of a significant drop in short interest in...
SMA Solar Technology AG (OTCMKTS:SMTGY) Short Interest Update
SMA Solar Technology AG (OTCMKTS:SMTGY – Get Free Report) was the target of a large growth in short interest in...
Trump Meets With Zelenskyy, Says He ‘Learned a Lot’ but His Viewpoint Is Unchanged
By Jackson Richman Former President Donald Trump met with Ukrainian President Volodymyr Zelenskyy on Sept. 27 as the GOP presidential...